Clinics & testing
Function Health vs Superpower: Which Lab Membership Wins?
Function Health vs Superpower, graded honestly: nearly identical 100+ lab memberships that both test without treating. The tiebreaker isn't the marker count.
On this page
Featured partner
Grade B
CoreAge Rx
Clinician-reviewed NAD+ and sermorelin with published starting prices and human support. Confirm the full cost and renewal terms before paying.
$93–$99/mo (starting rates)
We may earn a commission through this link, at no extra cost to you.
Check availability- Pricing
- Varies by plan
- Pharmacy
- 503A compounding pharmacy
- Labs
- Depends on treatment
- Consult
- Clinician review included
- Support
- Human support included
Grades come from each provider's published terms. How we're funded
Partner
Grade B
Strut Health
The cheapest published month-to-month sermorelin here, with the visit and follow-up care genuinely inside it.
$99–$119/mo
We may earn a commission through this link, at no extra cost to you.
Visit Strut HealthRegulatory record: FDA warning letter · February 2026 — see our full Strut Health review.
The headline requires auto-refill; the one-off price is 18% higher and is not published anywhere on the site. Compounded and not FDA-approved. Graded on the same rubric as every other provider on our scorecard.
The one-sentence version
Function Health and Superpower are far more alike than their marketing — or their lawsuit — suggests. Both are direct-to-consumer (DTC) lab memberships built around a "100+ biomarker" baseline panel, a retest, a flag-it-against-optimal-ranges dashboard, and physician-ordered labs. Both share the same decisive limit: they test, they don't treat. So the honest comparison isn't "which has more markers" (a near-meaningless axis) but "which more reliably surfaces the four or five cheap, outcome-validated numbers that actually matter, at a price you'll pay, without padding or upsell pressure." On that axis it's close, and the tiebreaker is track record and how you read flags — not the headline count. For the field context, start with our pillar on longevity medicine: what's proven vs hyped and our breakdown of what longevity biomarker panels actually test.
What each one is
- Function Health is the category's headline act: a $365-a-year membership built around a 160+ lab-test baseline panel plus a mid-year retest, with physician-ordered and -reviewed labs and a dashboard flagging results against "optimal" ranges. Full breakdown in our Function Health review.
- Superpower is the newer challenger, selling a 150+ biomarker baseline plus retest for $349 a year ($299 in the first year with its new-member discount), a polished app, and physician-ordered labs, positioned on aggressive price-per-marker. Full breakdown in our Superpower Health review.
Treat all dollar figures as current market info — DTC lab pricing and tiers shift constantly. The structural product is nearly the same on both sides.
Head to head
| Function Health | Superpower | |
|---|---|---|
| Model | DTC lab membership | DTC lab membership |
| Panel | 160+ lab tests + retest | 150+ biomarkers + retest |
| Price | $365/yr | $349/yr ($299 first year) |
| Track record | More established | Newer / less proven |
| Outcome-validated core | ApoB, Lp(a), hs-CRP, HbA1c | ApoB, Lp(a), hs-CRP, HbA1c |
| Treats your results? | No | No |
| Edge | Track record | Price |
The thing both get right
Give both their due: a standard annual physical orders a basic lipid panel, a metabolic panel, and a CBC, then stops. Both Function and Superpower routinely include markers with strong hard-outcome evidence that your checkup probably skips:
- ApoB counts the number of atherogenic particles; when it disagrees with standard LDL cholesterol, the particle count is the better predictor of cardiovascular events1.
- Lp(a), a genetically set particle, causally raises heart-attack and stroke risk per Mendelian-randomization data2 — measured once.
- hs-CRP predicted cardiovascular events at least as well as LDL cholesterol in a large prospective study3.
- HbA1c predicted all-cause and cardiovascular mortality continuously in a population study, including below the diabetes threshold4.
If either membership gets those four numbers in front of a motivated person, it has earned a real slice of its fee. That core is the same on both — which is exactly why the marker-count war between them is mostly noise.
The thing both get wrong (identically)
Both lean on the "100+ biomarkers" headline, and the framing does the same marketing work on each side:
- Roughly half is ordinary bloodwork (CBC, metabolic, lipids, thyroid) available cheaper through a primary-care order.
- Much of the tail is correlated padding — markers that track the cheap Tier-1 core and add line items, not independent signal.
- A few featured markers mislead as targets — IGF-1, sold as a youth hormone, has a U-shaped mortality curve. And the two biggest longevity levers in epidemiology aren't on any blood panel: cardiorespiratory fitness, among the strongest survival predictors ever measured5, and grip strength, which outpredicted blood pressure across 17 countries in PURE6.
Decisively, neither treats you. Both flag a high ApoB or a creeping HbA1c; neither titrates your statin or builds and rechecks a plan. For a health-literate buyer with a clinician who'll act, that's fine; for someone hoping the subscription itself improves their health, it's a category error on both sides. We map this whole DTC band in longevity clinics vs lab memberships.
Graded scorecard
- ASurfacing ApoB, Lp(a), hs-CRP, HbA1c (both panels)Strong evidence
Outcome-validated markers a basic checkup skips. ApoB beats LDL-C when they disagree; HbA1c predicts mortality continuously; Lp(a) is causal and measured once.
- BThe basic-labs half (both panels)Moderate evidence
Useful and treatable when abnormal — but ordinary bloodwork available more cheaply, not 'longevity' magic.
- CThe '100+ biomarker' framing as a health upgradeWeak evidence
Much of the tail is correlated padding on both; IGF-1 has a U-shaped mortality curve. Marker count is not the right axis.
- DEither membership as a health interventionInsufficient
Both test but don't treat. Surfacing a flagged number is not moving an outcome; cardiorespiratory fitness and grip strength — the biggest survival levers — aren't on either panel.
So what actually separates them?
Three honest, second-order differences — none of them the marker count:
- Track record. Function is the more established of the two with a longer operating history; Superpower is newer and less track-recorded. If "who's been running labs reliably longer" matters to you, Function has the edge today.
- Price posture. The list prices are now close — $349 a year for Superpower ($299 in the first year) against $365 for Function — so price alone rarely decides it. If you're buying purely to get ApoB/Lp(a)/hs-CRP/HbA1c and you'll act on them yourself, Superpower's first-year discount makes it the cheaper start.
- The lawsuit is a non-factor for buyers. In 2025 Function sued Superpower in a dispute centered on a former Function employee and trade-secret allegations. That's a business-and-personnel fight between competitors. It tells you the space is crowded; it tells you nothing about which panel is clinically better. Don't let it tip your decision.
The grade, and how we got there
We grade each on two axes, because conflating them is the trap both share:
- As a way to surface outcome-validated markers your checkup skips: moderate-to-strong for both. The core is real and nearly identical.
- As a "100+ biomarker" health upgrade: weak for both. Half is basic labs, the tail is padding, and neither treats.
That symmetry is the whole story: both land at roughly a B for the actionable core and a C for the model most people think they're buying. The split between them is narrow — Function edges it on track record, Superpower on price — so the right pick is whichever gets the four markers that matter in front of a clinician who'll act, for the price you'll actually pay. If neither sounds like what you want, a targeted outcome-validated panel plus treatment beats either, and we run that cost-benefit in are longevity clinics worth it?.
Who should pick which
- Pick Function if you value the longer operating track record and a more established dashboard, and $365 a year fits.
- Pick Superpower if you're buying purely on price-per-marker for the outcome-validated core and you'll act on results yourself.
- Pick neither if you're hoping a subscription will make you healthier. For most of that budget, a targeted panel plus actually treating the few markers that matter does more — and if you mainly want a biological-age number, the open PhenoAge formula derives one from a basic blood draw for free, covered in free biological-age tests. Don't confuse either blood membership with an epigenetic-age test — that's a different product, graded in biological age tests.
Bottom line
Function Health vs Superpower is a near-tie because they're nearly the same product: a 100+ marker baseline, a retest, a flag-it dashboard, physician-ordered labs — and the same decisive limit, that both test without treating. Their real value on both sides is the four or five cheap, outcome-validated markers (ApoB, Lp(a) once, hs-CRP, HbA1c) they surface; their shared weakness is the padded count and the missing treatment. Function edges it on track record, Superpower on price, and the 2025 lawsuit between them is a business story, not a clinical verdict. Pick the one that gets the markers that matter to a clinician who'll act, for the price you'll pay. To see where both rank against InsideTracker and Lifeforce, see our roundup of the best longevity blood test services. For a graded look at the labs and clinics selling these memberships, see our longevity clinic rankings.
Frequently asked questions
Function Health vs Superpower — which is better?
They're nearly the same product: a 100+ marker baseline panel plus a retest, a flag-it dashboard, physician-ordered labs, and the same decisive limit that both test without treating. Both surface the cheap outcome-validated core (ApoB, Lp(a), hs-CRP, HbA1c) and both pad the count with ordinary bloodwork. The narrow tiebreakers: Function has the longer operating track record, Superpower competes harder on price-per-marker. Pick whichever gets the markers that matter to a clinician who'll act, at the price you'll pay.
Is Superpower cheaper than Function Health?
Superpower lists $349 a year ($299 in the first year for new members) and Function lists $365 a year, so Superpower is the cheaper start but the gap is small. DTC lab pricing and tiers change often, so check both sites before you buy. But a lower price often just means more of the panel is ordinary-bloodwork filler; judge on whether the actionable core (ApoB, Lp(a), hs-CRP, HbA1c) is reliably included, not on the headline marker count or the sticker price alone.
Does the Function vs Superpower lawsuit affect which I should buy?
No. In 2025 Function Health sued Superpower in a dispute centered on a former Function employee and trade-secret allegations — a business and personnel fight between competitors. It signals how crowded the DTC lab space is, but it tells you nothing about which company's panel is clinically better. Base your decision on track record, price, and whether you'll act on the results, not on litigation headlines.
Do either Function or Superpower treat your results?
Neither does. Both surface results against 'optimal' ranges with physician-ordered labs, but neither is a clinic that titrates a statin, builds a nutrition plan, and rechecks. Acting on an abnormal result falls to you and your own clinician on both sides. That test-but-don't-treat structure is the defining limit of the whole DTC lab category and the main reason a subscription isn't itself a health intervention.
References
- Glavinovic T, Thanassoulis G, de Graaf J, et al. (2022). Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. Journal of the American Heart Association.
- Clarke R, Peden JF, Hopewell JC, et al. (2009). Genetic variants associated with Lp(a) lipoprotein level and coronary disease. New England Journal of Medicine.
- Ridker PM, Rifai N, Rose L, et al. (2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine.
- Khaw KT, Wareham N, Luben R, et al. (2001). Glycated hemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ.
- Mandsager K, Harb S, Cremer P, et al. (2018). Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open.
- Leong DP, Teo KK, Rangarajan S, et al. (2015). Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Function Health Review: Are 160+ Biomarkers Worth $365/yr?
Function Health's 160+ lab membership surfaces real outcome-validated markers — but roughly half are basic labs, and it tests without treating. Honest review.
ReadBest Longevity Blood Test Services, Compared (2026)
Function, InsideTracker, Lifeforce, Superpower — graded honestly. The four cheap outcome-validated markers matter; the '100+ biomarker' count mostly doesn't.
ReadFunction Health vs InsideTracker: Which Lab-Test Membership Wins?
Function casts a wide 160+ marker net; InsideTracker pairs fewer markers with an algorithm. We grade breadth, actionability, price — and who each fits.
ReadLongevity Clinics vs Lab Memberships vs Rx Telehealth: What Each Delivers
The longevity market splits into four bands: concierge clinics, membership programs, DTC labs, single-product Rx. What each delivers, and who it's for.
ReadLifeforce Health Review: Membership Cost and Whether It Is Worth It
Lifeforce bundles a clinician and Rx onto a ~50-marker quarterly panel for ~$149/mo. That crosses test-into-treat — but the panel is narrow and the upsell real.
ReadSuperpower Health Review: Is the $349 Lab Membership Worth It?
Superpower's $349/yr membership ($299 the first year) runs 150+ lab tests over two draws. The useful core is small, the panel padded, treatment unpriced.
Read